Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone.

DuPont HL, DuPont AW, Tillotson GS

Open source

DOI
10.1177/17562848241253089
Published
2024
Container
Therapeutic advances in gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17562848241253089,
  title = {Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone.},
  author = {DuPont HL and DuPont AW and Tillotson GS},
  year = {2024},
  journal = {Therapeutic advances in gastroenterology},
  doi = {10.1177/17562848241253089},
  url = {https://doi.org/10.1177/17562848241253089}
}

RIS

TY  - JOUR
TI  - Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone.
AU  - DuPont HL
AU  - DuPont AW
AU  - Tillotson GS
PY  - 2024
JO  - Therapeutic advances in gastroenterology
DO  - 10.1177/17562848241253089
UR  - https://doi.org/10.1177/17562848241253089
ER  - 

APA

HL, D., AW, D., & GS, T. (2024). Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone.. Therapeutic advances in gastroenterology. https://doi.org/10.1177/17562848241253089

Source records